Multimodal Anesthesia in Robotic Laparoscopic Nephrectomy
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorFundacio Puigvert
About this trial
It is a prospective, randomized, controlled and superiority clinical trial, with the objective of comparing the effectiveness of multimodal anesthesia versus conventional anesthesia in patients undergoing oncological robotic nephrectomy within a short-stay surgery program (SSA). The effect of no specific drug will be evaluated, but rather the anesthetic approach ologies of surgical patients. The clinical trial will be carried out in a third-level university hospital, between the first half of 2026 and the second half of 2027 and, after approval by the corresponding Clinical Research Ethics Committee.
Eligibility criteria
Qualifiers
Patients ≥18 years.
Indication for elective oncological robotic partial or radical nephrectomy.
ASA classification I-III.
Candidates for short-stay surgery according to institutional protocol.
Disqualifiers
Chronic opioid use. Defined as continuous opioid use during the 3 months prior to surgery
Uncontrolled chronic pain. Defined as chronic pain not adequately controlled with usual treatment during the 3 months prior to surgery.
Contraindications to NSAIDs, regional anesthesia, or drugs of the multimodal protocol.
Advanced renal failure (GFR <30 ml/min) at the preanesthetic visit.
Trial design
Treatments tested in this trial
- Multimodal anesthesia
- Conventional anesthesia
Treatment groups
80 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov